EUVIMEDEUVIMED entdecken
Crossref

Hyperthermia maintains death receptor expression and promotes TRAIL ‐induced apoptosis

Go Ohara, Kazuto Okabe iD, Naoto Toyama, Yuya Ohta, Song Xinman, Norihisa Ichimura, Kotaro Sato, Yusuke Urata, Hideharu Hibi

Journal of Oral Pathology & Medicine · 2023

DOI: 10.1111/jop.13457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2023. Verfasst von Go Ohara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hyperthermia, Induced, Mouth Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor necrosis factor‐related apoptosis‐inducing ligand activates apoptotic pathways and could potentially be used in anticancer treatments. However, oral squamous cell carcinoma cells are known to be resistant to tumor necrosis factor‐related apoptosis‐inducing ligand‐induced cell death. It has been previously reported that hyperthermia upregulates tumor necrosis factor‐related apoptosis‐inducing ligand‐induced apoptosis in other cancers. As such, we evaluated whether hyperthermia upregulates tumor necrosis factor‐related apoptosis‐inducing ligand‐mediated apoptosis in a tumor necrosis factor‐related apoptosis‐inducing ligand‐resistant oral squamous cell carcinoma cell line.

Methods

The oral squamous cell carcinoma cell line HSC3 was cultured and divided into hyperthermia and control groups. We investigated the antitumor effects of recombinant human tumor necrosis factor‐related apoptosis‐inducing ligand using cell proliferation and apoptosis assays. Additionally, we measured death receptor 4 and 5 levels, and determined death receptor ubiquitination status, as well as E3 ubiquitin ligase targeting of death receptor in both hyperthermia and control groups before recombinant human tumor necrosis factor‐related apoptosis‐inducing ligand administration.

Results

Treatment with recombinant human tumor necrosis factor‐related apoptosis‐inducing ligand produced greater inhibitory effects in the hyperthermia group than in the control group. Moreover, death receptor protein expression in the hyperthermia group was upregulated on the cell surface (and overall), although death receptor mRNA was downregulated. The half‐life of death receptor was several hours longer in the hyperthermia group; concomitantly, E3 ubiquitin ligase expression and death receptor ubiquitination were downregulated in this group.

Conclusion

Our findings suggested that hyperthermia enhances apoptotic signaling by tumor necrosis factor‐related apoptosis‐inducing ligand via the suppression of death receptor ubiquitination, which upregulates death receptor expression. These data suggest that the combination of hyperthermia and tumor necrosis factor‐related apoptosis‐inducing ligand has implications in developing a novel treatment strategy for oral squamous cell carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHead and Neck NeoplasmsHyperthermia, InducedMouth NeoplasmsHumansApoptosisApoptosis Regulatory ProteinsCell Line, TumorLigandsReceptors, TNF-Related Apoptosis-Inducing LigandSquamous Cell Carcinoma of Head and NeckTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alphaUbiquitin-Protein Ligases

Stichwörter der Autor:innen

death receptorhyperthermiaoral squamous cell carcinomatumor necrosis factor-related apoptosis-inducing ligandubiquitin

Substanzen

Apoptosis Regulatory ProteinsLigandsReceptors, TNF-Related Apoptosis-Inducing LigandTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor-alphaUbiquitin-Protein LigasesTNFSF10 protein, human

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Oral and Maxillofacial Surgery, Iwata City Hospital, Iwata, Japan.
  • Department of Oral and Maxillofacial Surgery, Nagoya University Hospital, Nagoya, Japan.

ORCID-Profile: Kazuto Okabe

Förderung

  • JSPS KAKENHI

Zitieren

APA

Ohara, G., Okabe, K., Toyama, N., Ohta, Y., Xinman, S., Ichimura, N., Sato, K., Urata, Y., & Hibi, H. (2023). Hyperthermia maintains death receptor expression and promotes TRAIL ‐induced apoptosis. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13457

Vancouver

Ohara G, Okabe K, Toyama N, Ohta Y, Xinman S, Ichimura N, et al. Hyperthermia maintains death receptor expression and promotes TRAIL ‐induced apoptosis. Journal of Oral Pathology & Medicine. 2023. doi:10.1111/jop.13457

BibTeX
@article{Ohara2023,
  author = {Ohara, Go and Okabe, Kazuto and Toyama, Naoto and Ohta, Yuya and Xinman, Song and Ichimura, Norihisa and Sato, Kotaro and Urata, Yusuke and Hibi, Hideharu},
  title = {Hyperthermia maintains death receptor expression and promotes TRAIL ‐induced apoptosis},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2023},
  doi = {10.1111/jop.13457}
}
Kostenlos starten →